Interagency Communication On Trial Designs Urged At FDA/NIH Stakeholder Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
New FDA/NIH council co-chaired by FDA Commissioner Hamburg and NIH Director Collins includes six additional members from each agency.